The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens-Reference-Cited by-同舟云学术

The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens

Published:2012-08 Issue:4 Volume:24 Page:217-220
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Kaya Ali Osman,Coskun Ugur,Gumus Mahmut,Dane Faysal,Ozkan Metin,Isıkdogan Abdurrahman,Alkis Necati,Buyukberber Suleyman,Yumuk Fulden,Budakoglu Burcin,Demirci Umut,Berk Veli,Bilici Ahmet,Inal Ali,Arpacı Erkan,Benekli Mustafa,for the Anatolian Society of Medica

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference23 articles.

1. IARC. GLOBOCAN Cancer Fact Sheets: Stomach Cancer [Internet]. Lyon: IARC. Available from: http://globocan.iarc.fr/factsheet.asp

2. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer

3. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

4. Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

5. Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and non-genetic risk factors of irinotecan-induced severe neutropenia in Chinese adult inpatients;Medicine;2023-03-03

2. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-03

3. Determination of the UGT1A1 polymorphism as guidance for irinotecan dose adjustment in gastric cancer treated with second-line chemotherapy;2022-09-06

4. Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis of Gastric Cancer;Cancer Regional Therapy;2019-12-11

5. Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China;PLOS ONE;2016-01-28